Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Egfr-Cells'

Egfr-Cells published presentations and documents on DocSlides.

x0000x0000Tel 613 8603111 Fax 613 860377 Dalhousie Street
x0000x0000Tel 613 8603111 Fax 613 860377 Dalhousie Street
by harmony
The standards of the Canadian Associat ion of Radi...
Nanotek & Expo 2014
Nanotek & Expo 2014
by DaintyLittlePrincess
Biodegradable . nanobrushes. for drug delivery. ...
Renoprotection with new
Renoprotection with new
by DiamondsAreForever
antidiabetic. drugs. Amouzegar. MD. Endocrine Re...
Chronic Kidney Disease and Cardiovascular Risk
Chronic Kidney Disease and Cardiovascular Risk
by Younggunner
Heather Mascio, DO. Introduction. Chronic Kidney D...
Vascular Access Placement in Patients with Incident CKD Stage 4 and 5 attending an Inner City Nephr
Vascular Access Placement in Patients with Incident CKD Stage 4 and 5 attending an Inner City Nephr
by Pirateking
Narender Goel et al.. Middletown Medical PC,. Mon...
Beth Sandy, MSN, CRNP Nurse Practitioner
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
In-Silico and In-Vitro
In-Silico and In-Vitro
by Rebelious
. Study of Benzanilide Derivatives as a Potent . A...
UK Renal Registry 23rd Annual Report
UK Renal Registry 23rd Annual Report
by hanah
Data to 31/12/2019. Figure 4.1 . Pathways adult pa...
UK Renal Registry 22nd Annual Report
UK Renal Registry 22nd Annual Report
by anya
Data to 31/12/2018. Figure 3.1 . Pathways adult pa...
Wednesday, March 25 th , 2020
Wednesday, March 25 th , 2020
by amber
ncoda.org. ncoda.org. Zoom Controls. ncoda.org. St...
Cetuximab Drugbank ID :
Cetuximab Drugbank ID :
by pagi
DB00002 . Protein Chemical formula : . C. 6484. H....
Management of Chronic Kidney Disease (CKD)
Management of Chronic Kidney Disease (CKD)
by ella
Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I...
CKD Nilang Patel Epidemiology of CKD
CKD Nilang Patel Epidemiology of CKD
by pamela
Definition of CKD. Staging of CKD. Etiology of CKD...
Serum Creatinine and
Serum Creatinine and
by valerie
eGFR. . Where . A. re . W. e Now?. Dr Mike Bosomw...
2019 Annual Data Report
2019 Annual Data Report
by layla
2019 . Annual Data Report . Chapter 2 TCCKD. Chap...
by warlikebikers
cancer. , right vs . left. : . how. to take . it....
Nouveautés dans le CBNPC métastatique
Nouveautés dans le CBNPC métastatique
by vizettan
Celine Mascaux, MD, . PhD. Multidisciplinary . Onc...
SPN and Lung Cancer Adam J. Hayek, DO
SPN and Lung Cancer Adam J. Hayek, DO
by sequest
PGY-6. Pulmonary and Critical Care Fellow . GOALS....
Endocrine resistance: molecular pathways and rational development of targeted therapies
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. Università di Napoli Federico II. ...
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
Optimizing Nursing Management of Patients Receiving Novel Therapies for Advanced NSCLC
by southan
Beth . Eaby. -Sandy, MSN, CRNP, OCN. ®. Nurse Pra...
Please note, these are the
Please note, these are the
by disclaimercanon
actual. . video-recorded proceedings from the . l...
Drug a nd Herbal Induced
Drug a nd Herbal Induced
by celsa-spraggs
N. ephrotoxicity. Sayamon. . S. ukkha. . P. har...
Chronic Kidney Disease: Detection and Management in Primary Care
Chronic Kidney Disease: Detection and Management in Primary Care
by sherrill-nordquist
Chronic Kidney Disease: Detection and Management ...
The Role of Antiangiogenic Agents
The Role of Antiangiogenic Agents
by luanne-stotts
The Role of Antiangiogenic Agents in the Changin...
Murali Nagarajan 1 , Ramya
Murali Nagarajan 1 , Ramya
by aaron
Gaddikeri. 1. , . Kedar. Sharbidre. 1. , . Mira...
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
Tenofovir nephrotoxicity in resource limited setting of Western India : Higher rate of renal functi
by conchita-marotz
A.Dravid. 1. ,A.Sadre. 2. ,S.Dhande. 1. , A.Borka...
A PCP’s Guide to CKD Screening and Delaying Progression
A PCP’s Guide to CKD Screening and Delaying Progression
by luanne-stotts
Learning Objectives. Utilize appropriate screenin...
A Primary Care Approach to CKD Management
A Primary Care Approach to CKD Management
by myesha-ticknor
Learning Objectives. Facilitate timely testing an...
Systolic Blood Pressure Intervention Trial (SPRINT)
Systolic Blood Pressure Intervention Trial (SPRINT)
by pamella-moone
Principal Results. Paul K. Whelton, MB, MD, MSc. ...
NCI-Molecular Analysis for Therapy Choice
NCI-Molecular Analysis for Therapy Choice
by phoebe-click
(NCI-MATCH or EAY131). Interim Analysis Results....
High Impact Publication
High Impact Publication
by yoshiko-marsland
. Steven B. Maron. , Lindsay Alpert, . Heewon. ...
Analytical Team Faye Cleary
Analytical Team Faye Cleary
by phoebe-click
Lois Kim. Dr Sally Hull. Dr . Ben Caplin. Profess...
Clinical Management Module
Clinical Management Module
by stefany-barnette
4. . (b) . Risks and Side Effects. Overview. Res...
Renal Replacement Therapy: What the PCP Needs to Know
Renal Replacement Therapy: What the PCP Needs to Know
by tatiana-dople
Learning Objectives. Describe treatment options f...
Systolic Blood Pressure Intervention Trial (SPRINT)
Systolic Blood Pressure Intervention Trial (SPRINT)
by lois-ondreau
Principal Results. Paul K. Whelton, MB, MD, MSc. ...
Pharmacologic Approaches to Treating CKD in Type 2 DM (1)
Pharmacologic Approaches to Treating CKD in Type 2 DM (1)
by calandra-battersby
Metformin must be considered the cornerstone of t...
The direct oral anticoagulants (DOACs)
The direct oral anticoagulants (DOACs)
by faustina-dinatale
and major trauma. Dr. Tina . Biss. Consultant . ...
Chris Dobson Renal disease: AKI vs CKD
Chris Dobson Renal disease: AKI vs CKD
by kittie-lecroy
What is acute kidney injury (AKI). Hyperkalaemia....
Canadian Diabete
Canadian Diabete
by trish-goza
s Association Clinical Practice Guidelines. Treat...
Where we are with targeted
Where we are with targeted
by stefany-barnette
therapies . for . cholangiocarcinoma. Professor J...